Lamiaa Rougui

Lamiaa Rougui practices at Howard University Hospital in Washington, District of Columbia, part of Howard University.

Lamiaa Rougui's NPI, 1295266914, was assigned on March 23, 2017. Lamiaa Rougui holds District of Columbia license MD048399.

Lamiaa Rougui's primary practice is Howard University Hospital, at 2041 Georgia Ave NW, Washington, DC 20060 in The District County. The practice phone is (202) 745-6100.

Lamiaa Rougui's primary practice is Howard University Hospital in Washington, District of Columbia, part of Howard University. The medical group on file is Howard University Faculty Practice Plan.

Dmand AI tracks the electronic health record (EHR) system at each site where Lamiaa Rougui practices. Vendor and product names are available with a free account.

Pulmonary disease is Lamiaa Rougui's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Lamiaa Rougui is licensed in District of Columbia.

CMS data shows 260 Medicare services from Lamiaa Rougui across 4 procedure codes in 2024, for 87 Medicare patients. Medicare paid $39,453 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 87 Medicare patients who saw Lamiaa Rougui in 2024. The largest group is 65 to 74, with 32 patients. 75% of them have high blood pressure, and 74% have diabetes. 77% are also on Medicaid. Their average risk score is 3.24, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Lamiaa Rougui's median patient age at 60, with 55% women.

In 2024, Lamiaa Rougui wrote 60 Medicare Part D claims for 15 patients. 55% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $332 in total drug cost. In 2019, CMS named 17 claims across 1 drug.

Lamiaa Rougui accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 26 general payments to Lamiaa Rougui from 13 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 91% of the total. Actelion Pharmaceuticals US, Inc. paid the most, $350.